The company said healthy profitability was mainly on account of improved performance across business segments and lower research & development expenses.
The company’s consolidated revenues grew 34% to Rs 1,734 crore for Q4FY16 from Rs 1,298 crore in the corresponding quarter of previous fiscal.
Ebitda (earnings before interest, taxes, depreciation and amortization) margin stood at 27% in Q4FY16 against 15% in Q4FY15.
Piramal Enterprises is one of India’s large diversified companies, with a presence in healthcare, healthcare information management and financial services.
Thus far in 2016, the stock outperformed the market by gaining 32% as compared to 1.4% decline in the S&P BSE Sensex.
At 10:13 am, the stock was up 3.5% at Rs 1,317 with a combined 104,300 shares changed hands on the counter on the BSE and NSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)